AIM2 and Parkinson disease: Here, we explored the function of the Parkinson’s disease-associated mitochondrial serine protease HtrA2 in the inflammasome pathway and report that HtrA2 regulates a mitochondrial quality control mechanism that selectively inhibits ASC-dependent NLRP3 and AIM2 inflammasomes in an agonist-dependent manner.